Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial
Laboratory Automation & Robotics

Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial

Lana Keisha Jul 17, 2026 0

San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jul 14, 2026 0

For millions worldwide, the diagnosis of actinic keratosis (AK) marks the beginning of a challenging journey to prevent skin cancer.…

Read More
Stem Cell & Regenerative Medicine

Molecular Switch Discovery at Weill Cornell Medicine Enhances Blood Stem Cell Regeneration and Bone Marrow Transplant Efficacy

Dwi Wanna Jul 4, 2026 0

The discovery of a singular molecular mechanism that governs the transition of blood stem cells from a dormant state to…

Read More
Laboratory Automation & Robotics

Eli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 Trials

Lana Keisha Jun 25, 2026 0

INDIANAPOLIS, IN – Eli Lilly and Company has announced groundbreaking Phase 3 trial results for its investigational drug, retatrutide, a…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 24, 2026 0

For millions worldwide, the diagnosis of actinic keratoses (AK) initiates a challenging journey to prevent the progression to skin cancer.…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 16, 2026 0

Rubedo Life Sciences, an AI-driven biotech startup focused on longevity, has announced positive preliminary results from its Phase 1b/2a study…

Read More
Laboratory Automation & Robotics

Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness

Lana Keisha Jun 2, 2026 0

For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…

Read More
Neuroscience & Brain Research

NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus

Rifan Muazin Jun 2, 2026 0

The National Institutes of Health (NIH) has released a groundbreaking study detailing the complex intracellular signaling processes triggered by GLP-1…

Read More
Pharmaceutical R&D

Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option

Teuku Ryan May 14, 2026 0

On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…

Read More
Laboratory Automation & Robotics

Can live cell dynamics fix drug discovery’s efficacy problem?

Lana Keisha Apr 28, 2026 0

The pharmaceutical industry finds itself at a critical juncture, grappling with escalating costs, protracted timelines, and persistently high failure rates…

Read More

Posts pagination

1 2
Abacus AI Unveils Integrated Platform Revolutionizing Software Development Through AI-Powered Agent Collaboration and ‘Vibe Coding’Bistrifluron: A Promising New Chemical Offers Targeted Defense Against Destructive Drywood TermitesRegulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings – Pharmaceutical TechnologyFive Python Scripts Revolutionize Excel Data Management, Streamlining Tedious Tasks for Professionals
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ